The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Open accessAbstract
The permeability of insulin (Ins), nerve growth factor (NGF), albumin (Alb), transferrin (Trf), and IgG across the blood-nerve barrier (BNB) and blood-brain barrier (BBB) in normal adult rats was quantified by measuring the (permeability coefficient x surface area) product (PS) with the i.v. bolus-injection technique in the cannulated brachial vein and artery using radioiodinated proteins. The PS values of the BNB for IgG and Alb were low: 0.079 +/- 0.029 x 10(-6) and 0.101 +/- 0.088 x 10(-6) ml.g-1.s-1, (mean +/- SD, respectively). The PS values for NGF and Trf were 16.1-fold and 25.5-fold higher than for Alb. The PS for Ins across the BNB was 33.190 +/- 2.053 x 10(-6) ml.g-1.s-1--a remarkable 329-fold increase compared with Alb. The PS values of the BBB for IgG and Alb in different brain regions were all low, from 0.028 +/- 0.017 to 0.151 +/- 0.035 x 10(-6) ml.g-1.s-1 (mean +/- SD). NGF and Trf had comparable PS values from 13- to 32-fold higher than for Alb, except for the brain stem, where the PS for Trf was 66-fold higher than for Alb. The mean PS for Ins across the BBB ranged from 15.78 +/- 5.45 x 10(-6) ml.g-1.s-1 for the cortex to 22.62 +/- 7.50 x 10(-6) ml.g-1.s-1 for the brain stem--again a remarkable 105- to 390-fold increase relative to Alb. Because reliable PS measurements were obtained for all proteins tested, the BBB and BNB cannot be considered impermeable to proteins--a concept that has plagued brain- and nerve-barrier research. The low PS values for IgG and Alb indicate low rates of transfer; however, Alb, in particular, is the major protein of endoneurial and ventricular fluid, which suggests that these PS values may be significant. Ins had the highest PS values, which likely reflect the mechanism of transport across the barriers--that is, receptor-mediated transport. Because NGF and Trf had PS values 13- to 66-fold higher than for Alb, whether this reflects receptor-mediated uptake, adsorptive-mediated transcytosis, or some other mechanism is unclear. That the PS values for NGF and Trf differ from Alb and IgG clearly suggests, however, a different uptake mechanism. Finally, the remarkably high PS values for Ins across the BBB and BNB identify this protein and its putative receptor on capillary endothelial cells as a potential target for drug delivery into the central and peripheral nervous systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mAbs exhibit limited distribution to the brain, and mAb concentrations was determined to be 0.1–0.2 % and 0.02 % of the steady‐state circulating mAb concentration in rodents and cynomolgus monkey, respectively.92, 93”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
In the citing paper
“the PK of the anti‐Her2/CD3T cell‐dependent bispecific (TDB) antibody in rats demonstrated similar clearance and half‐life as trastuzumab.92”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808
An immunohistochemical study of the nerve growth factor receptor in developing rats
Yan, Q., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03481.1988 · Cited by 605
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 550
Taniuchi, M., Clark, H., Schweitzer, J. B., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-02-00664.1988 · Cited by 542
Receptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 474
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 454
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 410
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–378 of 378
Drug Disposition and Targeting
Rochat, B., & Audus, K. L. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46812-3_6 · Cited by 5
Molecular Anatomy of the Blood-Brain Barrier in Development and Aging
Krause, D., Faustmann, P. M., & Dermietzel, R. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-105-3_16 · Cited by 7
Wilton, D. K., Mastro, K. J., Heller, M. D., Gergits, F. W., Willing, C. R., Frouin, A., Daggett, A., Gu, X., Kim, A. Y., Faull, R. L. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471180 · Cited by 5
Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma
Kourtesakis, A., Bailey, E., Chow, H. N. H., Rohdjeß, H., Mussnig, N., Agardy, D. A., Hoffmann, D. C. F., Chih, Y., Will, R. D., Kaulen, L. D., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2518631 · Cited by 5
Salian, V. S., Curran, G. L., Lowe, V. J., Tang, X., Kalari, K. R., & Kandimalla, K. K. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100088 · Cited by 4
Self-citationMechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats
Gao, X., Sheng, Y.-H., Yu, S., Li, J., Rosa, R. L., Girgis, S., Guo, T., Brunetti, L., & Kagan, L. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03496-y · Cited by 4
Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders
Shelly, S., Dubey, D., Mills, J. R., & Klein, C. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00020-7 · Cited by 4
Passive Immunotherapy in Alzheimer’s Disease
Dolan, P. J., & Zago, W. M. (2018) · InTech eBooks · doi:10.5772/intechopen.76299 · Cited by 4
Perspectives on optimizing local delivery of drugs to peripheral nerves using mathematical models
Laranjeira, S., Roberton, V. H., Phillips, J. B., & Shipley, R. J. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1593 · Cited by 4
Calcitonin pump improves nerve regeneration after transection injury and repair
Yan, J., LoGiudice, J. A., Davis, J., Zhang, L., Agresti, M., Sanger, J. R., Matloub, H. S., & Havlik, R. J. (2014) · Muscle & Nerve · doi:10.1002/mus.24281 · Cited by 4
Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease
Steinitz, M. O. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.5.633 · Cited by 5
Ghosh, S., Fan, Y., Laufer, B. I., Stephenson, W., Zang, N., Lawrence, J., Lin, H. H., Sen, S., Miller, S. E., Chu, S., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100303 · Cited by 3
Niazi, S. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810211 · Cited by 3
Wide range of clinicopathological features in immune‐mediated autonomic neuropathies
Koike, H., & Sobue, G. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12003 · Cited by 3
Tripathi, S., Pathak, S., & Kale, A. (2021) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-61985-5_12 · Cited by 3
Blood Supply and Microcirculation of the Peripheral Nerve
Prahm, C., Heinzel, J. C., & Kolbenschlag, J. (2021) · Reference series in biomedical engineering · doi:10.1007/978-3-030-06217-0_21-1 · Cited by 3
Antibodies and the Blood‐Brain Barrier
Jones, A. R., & Shusta, E. V. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch21 · Cited by 3
The Effects of Immunization against Cholecystokinin Fragment 30–33 in the Behavior of White Rats
Danilova, R. A., Рудько, О. И., Korotkova, T. M., Obukhova, M. F., & Ашмарин, И. П. (2002) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1013983626780 · Cited by 3
WU, W., Sivaneri, N. S., Akin, E., Spesia, C. J., Huang, Y. J., Bond, L. G., Doi, D. L. Q., Stad, J., Djouadi, A., Xie, Y., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01718-3 · Cited by 3
Blood-brain barrier breakdown and autoimmune cerebellar ataxia
Shimizu, F. (2024) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001932 · Cited by 2
An Immunochemical Approach to Model and Long-Term Suppression of Depressive and Anxiety Behavior
Ашмарин, И. П., Danilova, R. A., Рудько, О. И., Belopolskaya, M. V., Obukhova, M. F., & Shmalgausen, E. V. (2006) · The Spanish Journal of Psychology · doi:10.1017/s1138741600006119 · Cited by 2
Oishi, M., Shimizu, F., Sano, Y., Takeshita, Y., Maeda, T., Fujikawa, S., Honda, M., Sato, R., & Kanda, T. (2019) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12507 · Cited by 2
Pasechnik, V., & Price, J. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.10.1255 · Cited by 2
Bioanalytical Strategies to De‐risk CNS Drug Discovery for Novel Chemical Modalities
Summerfield, S. G., Fairman, D. A., & Yates, J. W. T. (2025) · doi:10.1002/9783527844678.ch9 · Cited by 2
Selection of LRP1 ligand phage-displayed single domain antibody that transmigrates BBB
Suárez, V. M., Catota, B. A. M., Camacho, F., Jara, N., Vera, M. A. C., Pérez, R. M., Lopez, F., Toledo, J. R., Henriquez, P. I. C., & Sánchez, O. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2434908 · Cited by 1
Chatterjee, P., Chakravarty, S., Biswas, N. K., Trivedi, S., Datta, A., & Mukhopadhyay, D. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114375 · Cited by 1
Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology
Caillierez, R., Leboullenger, C., Leclercq, S., Besegher, M., Bégard, S., Auger, F., Maurage, C., Accart, B., Mortelecque, J., Dupré, E., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01823-6 · Cited by 1
Cao, K., Xie, J., Liang, X., Li, Y., Gong, H., & Luo, H. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00917 · Cited by 2
CA-IV-directed small-molecule shuttle enables targeted brain delivery of biologics
Ding, X., Chen, X., Boehm, P., Carretero‐Cerdán, A., Jang, S., Sullivan, E. E., Arokiaraj, C. M., Ristic, F., Kavvathas, B., Campos, L., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02294-y · Cited by 1
Ашмарин, И. П., Danilova, R. A., Belopolskaya, M. V., Рудько, О. И., Obukhova, M. F., & Shmalgausen, E. V. (2007) · Neurochemical Journal · doi:10.1134/s1819712407020043 · Cited by 1
Useche, S., & Andrés, C. (2016) · UTA ResearchCommons (University of Texas Arlington) · Cited by 1
Impact of diabetes on cellular connections: Pathological insights and emerging therapeutic targets
Kanwal, A., Kanwar, N., Shetty, M. P., Rana, K., Alisi, A., Bhatia, A., & Bharati, S. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103300 · Cited by 1
Blood–Brain Barrier and Blood–Nerve Barrier
Sano, Y., & Kanda, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-55594-0_4 · Cited by 1
Mahoney, M. J., Krewson, C. E., Miller, J. A., & Saltzman, W. M. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.ft-161 · Cited by 1
Blood-Brain Barrier and Blood-Nerve Barrier
KANDA, T. (2005) · Yamaguchi Medical Journal · doi:10.2342/ymj.54.5 · Cited by 1
Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins
Zloković, B. V., Ghiso, J. A., & Frangione, B. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_20 · Cited by 1
Insulin and the Blood‐Brain Barrier
Banks, W. A., & Lim, W. S. (2006) · Wiley eBooks · doi:10.1002/9783527611225.ch12
ROLE OF THE ANG-TIE2 PATHWAY IN THE INVASIVE RECURRENCE OF GBM FOLLOWING ANTI-VEGF THERAPY
Cortes‐Santiago, N. (2014) · Digital Commons-TMC (Texas Medical Center)
Estructura normal de la barrera hematoneural
Arango, M. I. M. (2012) · Morfolia
Neurochemical and neuroendocrine reactions during non-neurological surgery
Anckarsäter, R. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Occlusion and brain function: mastication as a prevention of
No, Y.-S., Yamamoto, T., & Kubo, Y. (2010)
The Blood-nerve Barrier Breakdown and the Diabetic Neuropathy
Shimizu, F. (2014) · Yamaguchi Medical Journal · doi:10.2342/ymj.63.17
Estrategias reproductivas de moluscos gasterópodos
Giglio, M. L. (2019) · doi:10.35537/10915/72578
Ubogu, E. E. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_8
Autoantibodies in disorders of the brain
Зонг (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20191106sz
Statin-Mediated Attenuation of Chemokine Expression in Peripheral Nerve Vascular Endothelial Cells
Langert, K. A. (2012) · Loyola eCommons (Loyola University of Chicago)
Hellweg, R. (2000) · Monographien aus dem Gesamtgebiete der Psychiatrie · doi:10.1007/978-3-642-96006-2_17
(2004) · Elsevier eBooks · doi:10.1016/b978-0-443-06711-2.50006-8
Research Strategy of Anti-Transferrin Receptor Antibody Targeting Intracerebral Drug Delivery
范, 双. (2022) · Pharmacy Information · doi:10.12677/pi.2022.113017
Mahoney, M. J., Krewson, C. E., Miller, J. A., & Saltzman, W. M. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.ft-125
Principles of PET and Its Role in Understanding Drug Delivery to the Brain
Syvänen, S., Gunn, R. N., & Zhang, L. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_11
Increasing Brain Exposure of Antibodies
Lesuisse, D. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_2
Evidence for Cerebral Microvascular Injury in Head Trauma Involving Infants and Young Children
Castellani, R. J., Scholl, A. R., & Schmidt, C. J. (2022) · Journal of Forensic Science and Medicine · doi:10.4103/jfsm.jfsm_41_22
Investigation and description of the New Brain and New Mind hypotheses
Klinedinst, B. S. (2021) · doi:10.31274/td-20240329-457
Castonguay, A.-M., Morin, B., Parent, M., Durcan, T. M., Luo, W., Shlaifer, I., Julien, J., Gravel, C., & Lévesque, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.09.612044
Vega, M. R., Hansen, H. H., Jensen, C. S., Alexiou, E., Madsen, M. R., Wichern, F., Skytte, J. L., Salinas, C. G., Sotty, F., Jensen, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638216
Sandhu, J. K., Thakur, K., Cai, D., Péladeau, C. L., Hewitt, M., & Ghadban, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00055-3 · Cited by 1
Fluid and Imaging Markers of Synuclein Pathology
Paoletti, F. P., Gaetani, L., Bellomo, G., & Parnetti, L. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_3
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612336
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612333
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612327
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612324
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612348
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612330
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612345
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612342
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612339
Smith, C., Greenberg, B. M., Reynolds, J. R., Mosavi-Hecht, R. M., Semedo‐Kuriki, P., Benavides, S., Zhang, W., Wu, Y., Adams, G., Evers, B. M., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78149
Rajbanshi, B., & Guruacharya, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.28.708739
Sandhu, J. K., Tanha, J., & Arbabi‐Ghahroudi, M. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671675 · Cited by 1
Ding, Z., Gibson, K. A., Nascari, D. G., Tallant, L., Bouchal, S. M., Dickson, D. W., & Fryer, J. D. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70269
Guo, H., Savard, A., Manser, C., Dutta, K., Taylor, J. A., Rousseaux, M. W. C., Pozzi, S., Julien, J., Baird, S. D., & Gibbings, D. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01774-9
Nguyen, N., Yuan, M., & Wang, Y. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04201-5
Cole (2000) · doi:10.1002/1097-0029(20000815)50:4
Metadata
- Authors
- Poduslo, J. F., Curran, G. L., & Berg, C. T.
- Affiliations
- Mayo Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5705-5709
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC44065
- OpenAlex
- W2071079524
- Cited by
- 377
- References
- 82
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 16 · 2020: 32 · 2019: 16 · 2018: 20 · 2017: 16 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 19
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- blood-nerve barrier, blood-brain barrier, macromolecule permeability, protein permeability, insulin, nerve growth factor, transferrin, IgG, albumin, permeability coefficient, brain regions, brainstem, ventricular fluid, radioiodinated proteins, rats
- MeSH terms
- Albumins, Animals, Blood-Brain Barrier, Brain, Endocytosis, Insulin, Male, Metabolic Clearance Rate, Nerve Growth Factors, Permeability, Transferrin, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review